NCT06721611

A Comprehensive Optical Blood Pressure Assessment Tool to Identify Cases of Unscreened Hypertension Across an Active Population in the U.S.

A Comprehensive Optical Blood Pressure Assessment Tool to Identify Cases of Unscreened Hypertension Across an Active Population in the U.S.: a Prospective Single-center Observational Clinical Study.

• Status: Withdrawn
• Phase: —
• Study type: Observational
• Enrollment: 0 (actual)
• Sponsor: Nucor · Industry
• Sex: All
• Age: 25 Years – 70 Years
• Healthy volunteers: Accepted

Summary

To screen for and identify subjects with potential undiagnosed hypertension using an optical blood pressure monitoring device across an active workforce population in the US (Nucor employees).

Detailed description

100 voluntary Nucor facility employees with no previous diagnosis of hypertension will be recruited and will receive an optical blood pressure monitoring device (Aktiia G1 Device) that is a miniature bracelet placed in the wrist and measure blood pressure continuously without inflating. Each participant will wear the device continually during 28 days.

Conditions

• Hypertension

Interventions

Type	Name	Description
DEVICE	Optical Blood Pressure Monitoring Device (Aktiia G1)	Non-hypertensive Nucor employees that accept to wear an optical blood pressure monitoring device (Aktiia 24/7 device) to screen for and identify potential undiagnosed hypertension. 100 participants. Each participant will wear the device continuously for 28 days.

Timeline

• Start date: 2025-01-16
• Primary completion: 2025-07-16
• Completion: 2025-08-31
• First posted: 2024-12-06
• Last updated: 2025-02-06

Locations

1 site across 1 country: United States